Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans

Photodiagnosis Photodyn Ther. 2023 Dec:44:103822. doi: 10.1016/j.pdpdt.2023.103822. Epub 2023 Sep 29.

Abstract

Candida albicans readily develops resistance to fluconazole. Magnetic iron oxide nanoparticles (denoted as MION) and antimicrobial photodynamic therapy are attracting attention as therapeutic agents. This study aims to investigate the inhibitory efficacy of MION alone and combined with visible light against C. albicans and expression analysis of hyphal wall protein 1 (HWP1) and agglutinin-like sequence 1 (ALS1) genes in C. albicans. Antifungal susceptibility testing, photodynamic activity assay, reactive oxygen species (ROS) production assay and gene expression analysis were determined in C. albicans treated with MION alone and combined with visible light. MION at 1 × minimum inhibitory concentration (MIC) level (500 μg/mL) exhibited antifungal activity against C. albicans isolates. Further, 1 × MIC levels of MION alone and combined with visible light displayed remarkable fungicidal effects at 24 and 48 h after treatment. The MION combined with visible light caused the highest levels of ROS production by all C. albicans isolates. The relative RT-PCR data showed significant downregulation of HWP1 and ALS1 genes which are the key virulence genes in C. albicans. Differences in gene expression of HWP1 and ALS1 were more significant in MION combined with visible light treatments than MION alone. Our study sheds a novel light on facile development of effective treatment of C. albicans especially fluconazole-resistant C. albicans infections. The hyphae-specific genes HWP1 and ALS1 could be probable molecular targets for MION alone and combined with visible light in C. albicans.

Keywords: Candida albicans; Hyphae-specific genes; Magnetic iron oxide nanoparticles; Molecular target; Photodynamic therapy; Resistant.

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Biofilms
  • Candida albicans* / genetics
  • Fluconazole / pharmacology
  • Fungal Proteins / genetics
  • Fungal Proteins / metabolism
  • Fungal Proteins / pharmacology
  • Hyphae / metabolism
  • Light
  • Magnetic Iron Oxide Nanoparticles
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Reactive Oxygen Species

Substances

  • Fluconazole
  • Antifungal Agents
  • Fungal Proteins
  • Reactive Oxygen Species
  • monocrystalline iron oxide nanoparticle
  • Photosensitizing Agents